MRI with superparamagnetic iron oxide vs. double-spiral CT when identifying malignant liver lesions;MRT mit superparamagnetischen eisenpartikeln versus doppelspiral- CT beim nachweis maligner leberlasionen

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 168, Issue 5, 1998, Pages 436-443

  Muller R D ^a   Vogel, K ^a   Neumann, K ^a   Hirche, H ^a   Barkhausen, J ^a   Stoblen F ^a   Henrich, H ^a   Langer, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Focal liver lesions; Hepatocellular carcinoma; Metastases; MRI contrast agents; Spiral CT

Indexed keywords

CONTRAST MEDIUM; IOPROMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CARCINOMA; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COSTS AND COST ANALYSIS; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FERRIC COMPOUNDS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031750038     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. Amer J Roentgenol 1994; 163: 323 - 331
2. Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J. Lover metastases: Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657 - 663
3. Choi BI, Man JK, Cho JM, Choi DS, Han MC, Lee, Hyo-Suk, Kim CY. Characterization of focal hepatic tumors (value of two-phase computed tomography. Cancer 1995; 12: 2434 - 2442
4. Choi BI, Cho JM, Han JK, Choi DS, Han MC. Spiral CT for the detection of hepatocellular carcinomas: relative value of arterial- and latephase scanning. Abdominal Imaging 1996; 21: 440 - 444
5. Edelmann RR, Siegel JB, Singer A, Dupuis K, Longmaid, HE. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. Amer J Roentgenol 1989; 153: 1213 - 1219
6. Fretz CJ, Stark DD, Metz CE, Elizardo G, Weissleder R, Shen JH, Wittenberg J, Simeone J, Ferrucci JT. Detection of Hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. Amer J Roentgenol 1990; 155: 763 - 770
7. Grandin C, Van Beers BE, Robert A, Gigot JF, Greubel, A., Pringot J. Benign hepatocellular tumor: MRI after superparamagnetic iron oxide administration. J Comp Ass Tomogr 1995; 19: 412 - 418
8. Hagspiel KD, Neidl KFW. Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471 - 478
9. Halavaara J, Lamminen AE, Bondesstam S, Standertskjold-Nordenstam CG, Hamberg LM. Detection of focal liver lesions with superparamagnetic iron oxide: Value of STIR and SE imaging. J Comp Ass Tomogr 1994; 18: 897 - 904
10. Hamm B, Reichel M, Vogl T, Taupitz M, Wolf KG. Superparamagnetische Eisenpartikel. Fortschr Röntgenstr 1994; 160: 52 - 58
11. Hruby W, Stellamor K. Kontrastmittelverhalten von Lebertumoren im CT - Korrelation zwischen Pharmakokinetik und feingeweblichem Bau. Röntgen-Bl 1988; 41: 133 - 139
12. Laniado M, Chachiat A. Verträglichkeitsprofil von Endorem. Radiologe 1995; 35: 266 - 270
13. Marchai G, Van Hecke P, Demaerel P, Decrop E, Kennis C, Baert AL, van der Schueren E. Detection of liver metastases with superparamagnetic iron oxide in 15 Patients: Results of MR imaging at 1.5 T. Amer J Roentgenol 1989; 152: 771 - 775
14. Mirowitz SA, Lee JKT, Gutierrez E, Brown JJ, Heiken JP, Eilenberg SS. Dynamic gadolinium-enhanced rapid acquisition spin-echo MR imaging of the liver. Radiology 1991; 179: 371 - 376
15. Oestmann JW, Galanski M. ROC: Methodik zum Vergleich der diagnostischen Leistung bildgebender Verfahren. Fortschr Röntgenstr 1989; 151: 89 - 92
16. Ros PR, Feeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA. Hepatic MR imaging with ferrumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196: 481 - 488
17. Rummeny EJ, Weissleder R, Stark DD, Elizondo G, Ferrucci JT. Kernspintomographie fokaler Leber- und Milzläsionen. Radiologe 1988; 28: 380 - 386
18. Rummeny EJ, Reimer P, Daldrup H, Peters PE. Detektion von Lebertumoren. Radiologe 1995; 35: 252 - 258
19. Sachs L. Varianzanalytische Methoden. In: Sachs L, editor. Angewandte Statistik. Berlin-Heidelberg: Springer Verlag, 1992: 612 - 658
20. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, Ferrucci JT. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 1987; 162: 211 - 216
21. Saini S, Stark DD, Hahn PF, Bousquet JC, Introcasso J, Wittenberg J, Brady J. Ferrucci JT. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 1987; 162: 217 - 222
22. Schwartz LH, Seltzer SE, Adams DF, Tempany CM, Piwnica-Worms DR, Silverman SG, Herman L, Herman LT, Hooshmand R. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences. Invest Radiol 1994; 29: 21 - 23
23. Stark DD, Weissleder R, Elizando G, Hahn PF. Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168: 297 - 301
24. Taylor PM, Hawnaur JM, Hutchinson CE. Superparamagnetic iron oxide imaging of focal liver disease. Clin Radiol 1995; 50: 215 - 219
25. Urhan R, Adam G, Busch N, Chen JH, Euringer W, Günther RW. Superparamagnetische Eisenoxidpartikel: Welchen Stellenwert hat der T1-Effekt für die MR-Diagnostik fokaler Leberläsionen? Fortschr Röntgenstr 1996; 165: 364 - 370
26. Vogl ThJ, Hammerstingl R, Pegios W, Hamm B, Eibl-Eibesfeld A, Woessmer B, Lissner J, Felix R. Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen. Fortschr Röntgenstr 1994; 160: 319 - 328
27. Vogl ThJ. Hammerstingl R, Keck H, Felix R. Differentialdiagnose von fokalen Leberläsionen mittels MRT unter Verwendung des superparamagnetischen Kontrastmittels ENDOREM. Radiologe 1995; 35: 258 - 266
28. Weissleder R, Stark DD, Engelstadt BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics an toxicity. Amer J Roentgenol 1989; 152: 167 - 173
29. Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR jr, Elliot S. MR imaging with IV superparamagnetic iron oxide efficacy in the detection of focal hepatic lesions. Amer J Roentgenol 1993; 161: 1191 - 1198
30. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Hatanaka Y, Murakami R, Nishiharu T, Takahashi M, Higashida Y, Moribe N. Hepatocellular carcinoma in cirrhotic levers: Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195: 106 - 112
31. Zwicker C, Langer M, Astinet F, Langer R, Ulrich V, Felix R. Differenzierung maligner Lebertumoren mit schneller dynamischer CT. Fortschr Röntgenstr 1990; 152: 293 - 302